SE0103613D0 - Novel formulation - Google Patents
Novel formulationInfo
- Publication number
- SE0103613D0 SE0103613D0 SE0103613A SE0103613A SE0103613D0 SE 0103613 D0 SE0103613 D0 SE 0103613D0 SE 0103613 A SE0103613 A SE 0103613A SE 0103613 A SE0103613 A SE 0103613A SE 0103613 D0 SE0103613 D0 SE 0103613D0
- Authority
- SE
- Sweden
- Prior art keywords
- pectin
- active ingredient
- dosage form
- pharmaceutically active
- alginic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0103613A SE0103613D0 (sv) | 2001-10-30 | 2001-10-30 | Novel formulation |
ES02780231T ES2278978T3 (es) | 2001-10-30 | 2002-10-29 | Nueva formulacion. |
EP02780231A EP1450762B1 (en) | 2001-10-30 | 2002-10-29 | Novel formulation |
US10/493,711 US20050037081A1 (en) | 2001-10-30 | 2002-10-29 | Novel formulation |
DE60217710T DE60217710T2 (de) | 2001-10-30 | 2002-10-29 | Neue formulierung |
JP2003539643A JP2005507408A (ja) | 2001-10-30 | 2002-10-29 | 新規製剤 |
PCT/SE2002/001956 WO2003037299A1 (en) | 2001-10-30 | 2002-10-29 | Novel formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0103613A SE0103613D0 (sv) | 2001-10-30 | 2001-10-30 | Novel formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0103613D0 true SE0103613D0 (sv) | 2001-10-30 |
Family
ID=20285820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0103613A SE0103613D0 (sv) | 2001-10-30 | 2001-10-30 | Novel formulation |
Country Status (7)
Country | Link |
---|---|
US (1) | US20050037081A1 (ja) |
EP (1) | EP1450762B1 (ja) |
JP (1) | JP2005507408A (ja) |
DE (1) | DE60217710T2 (ja) |
ES (1) | ES2278978T3 (ja) |
SE (1) | SE0103613D0 (ja) |
WO (1) | WO2003037299A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7678817B2 (en) * | 2005-06-03 | 2010-03-16 | Medrx Co., Ltd. | Enteric medicinal composition for oral use |
US9993497B2 (en) | 2012-12-30 | 2018-06-12 | Hadasit Medical Research Services And Development Ltd. | Use of alginate compositions in preventing or reducing liver damage caused by a hepatotoxic agent |
WO2016195509A1 (en) * | 2015-06-03 | 2016-12-08 | Ewos Innovation As | Oral delivery system for bioactive agents |
WO2020230089A1 (en) | 2019-05-14 | 2020-11-19 | Clexio Biosciences Ltd. | Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease |
WO2022195476A1 (en) | 2021-03-15 | 2022-09-22 | Clexio Biosciences Ltd. | Gastroretentive devices for assessment of intragastric conditions |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2766124A (en) * | 1954-05-25 | 1956-10-09 | American Cyanamid Co | Antibiotic-containing ice composition |
GB1524740A (en) * | 1976-11-09 | 1978-09-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions for use in the suppression of gastric reflux |
US5034378A (en) * | 1988-12-15 | 1991-07-23 | James P. Cox | Synergistic flavor enhancement nutritional compositions and methods |
GB9514438D0 (en) * | 1995-07-14 | 1995-09-13 | Danisco | Stabilisation process and an enzyme for use in such a process |
US5721003A (en) * | 1996-03-18 | 1998-02-24 | Kraft Foods, Inc. | Foaming coffee creamer and instant hot cappuccino |
US5780055A (en) * | 1996-09-06 | 1998-07-14 | University Of Maryland, Baltimore | Cushioning beads and tablet comprising the same capable of forming a suspension |
US7674480B2 (en) * | 2000-06-23 | 2010-03-09 | Teva Pharmaceutical Industries Ltd. | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
US6887508B2 (en) * | 2002-02-20 | 2005-05-03 | Solae, Llc | Protein stabilizing agent |
-
2001
- 2001-10-30 SE SE0103613A patent/SE0103613D0/xx unknown
-
2002
- 2002-10-29 ES ES02780231T patent/ES2278978T3/es not_active Expired - Lifetime
- 2002-10-29 US US10/493,711 patent/US20050037081A1/en not_active Abandoned
- 2002-10-29 DE DE60217710T patent/DE60217710T2/de not_active Expired - Fee Related
- 2002-10-29 JP JP2003539643A patent/JP2005507408A/ja active Pending
- 2002-10-29 WO PCT/SE2002/001956 patent/WO2003037299A1/en active IP Right Grant
- 2002-10-29 EP EP02780231A patent/EP1450762B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20050037081A1 (en) | 2005-02-17 |
ES2278978T3 (es) | 2007-08-16 |
WO2003037299A1 (en) | 2003-05-08 |
EP1450762A1 (en) | 2004-09-01 |
DE60217710T2 (de) | 2007-11-15 |
DE60217710D1 (de) | 2007-03-08 |
JP2005507408A (ja) | 2005-03-17 |
EP1450762B1 (en) | 2007-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200700049A1 (ru) | Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением | |
ATE418324T1 (de) | Mucoadhäsive xyloglucan-haltige formulierung für medizinprodukte und pharmazeutische darreichungsformen | |
DE60120648D1 (de) | Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung | |
ATE424810T1 (de) | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung | |
EP0966966A3 (en) | Nefazodone dosage form | |
HUP0401569A2 (hu) | Amlodipint és atorvastatint tartalmazó gyógyászati készítmények és eljárás az előállításukra | |
WO2004108162A3 (en) | Controlled release pharmaceutical composition | |
WO2002088100A3 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
CY1107819T1 (el) | Φαρμακευτικη διαμορφωση της ολανζαπινης | |
SE0102440D0 (sv) | New compound | |
WO2003047552A3 (en) | Pharmaceutical composition comprising a 5ht1 receptor agonist | |
HRP20090022T3 (en) | Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences | |
CA2389032A1 (en) | Preventive or therapeutic agents for inflammatory diseases of intestine | |
CA2417935A1 (en) | Anti-inflammatory medicament | |
SE0103613D0 (sv) | Novel formulation | |
MXPA05008403A (es) | Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion. | |
WO2006094143A3 (en) | Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections | |
ATE319434T1 (de) | Pharmazeutische zusammensetzung für die kontrollierte freisetzung eines beta-lactam- antibiotikums | |
HUP0402093A3 (en) | 3-phenyl-2-phenethylthio-propionic acid derivatives as selective agonists of ppar-alpha, their preparation and pharmaceutical compositions containing them | |
EP1411956B8 (en) | Use of oversulfated polysaccharides as inhibitors of hiv | |
EP2022494A3 (en) | Laxative preparation containing l-Arginine | |
IT1306186B1 (it) | Sali non igroscopici di principi attivi ad attivita' terapeutica e/onutrizionale e composizioni atte alla somministrazione orale | |
WO2004073627A3 (en) | Novel therapeutic method and compositions for topical administration | |
FR2878443B1 (fr) | Composition pharmaceutique, destinee a l'administration par voie orale de principe(s) actif(s) fortement gastro-labile(s et sa preparation |